Exploratory genomic analysis of high grade neuroendocrine neoplasms across diverse primary sites.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-related cancer"
DOI: 10.1530/erc-22-0015
Abstract: High grade (grade 3) neuroendocrine neoplasms (G3 NENs) have poor survival outcomes. From a clinical standpoint, G3 NENs are usually grouped regardless of primary site and treated similarly. Little is known regarding the underlying genomics… read more here.
Keywords: grade neuroendocrine; high grade; neuroendocrine neoplasms; primary sites ... See more keywords